Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07187466 · ClinicalTrials.gov registry record · Phase 4
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
A Phase 4 study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- Phase 4
- Development phase
- 146
- Enrollment target
NCT07187466: Clinical Trial Phase 4 study, sponsored by VA Office of Research and Development.
NCT07187466 is a Phase 4 study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 146 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07187466, a Phase 4 study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 146 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about different treatments for overactive bladder symptoms in Parkinson's Disease. The investigators want to find out if people who do not respond to one treatment (either behavioral or drug treatment) will respond to combined treatment. The investigators also want to find out what factors influence whether someone responds to the treatments.
Interventions
- DRUG mirabegron
- BEHAVIORAL Exercise-based behavioral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2030-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07187466
The ClinicalTrials.gov registry entry for NCT07187466 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which mirabegron is the first listed.
NCT07187466 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07187466 about?
NCT07187466 is a clinical study titled "Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease". The purpose of this study is to learn about different treatments for overactive bladder symptoms in Parkinson's Disease. The investigators want to find out if people who do not respond to one treatment (either behavioral or drug treatment) will respond to combined treatment. The investigators also w...
What is the current status of trial NCT07187466?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 146 participants. The study started on 2026-07-01. Estimated completion is 2030-06-30.
What interventions are being tested in trial NCT07187466?
The interventions under investigation include: mirabegron (DRUG), Exercise-based behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07187466?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.